🇺🇸 autologous dendritic cells in United States
3 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 3
Most-reported reactions
- Cerebral Haemorrhage — 1 report (33.33%)
- General Symptom — 1 report (33.33%)
- Metastases To Central Nervous System — 1 report (33.33%)
Frequently asked questions
Is autologous dendritic cells approved in United States?
autologous dendritic cells does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for autologous dendritic cells in United States?
Cedars-Sinai Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.